Report Detail
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2026
- RnM4158769 |
- 25 August, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Non-steroidal Anti-inflammatory Drugs (NSAID) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-steroidal Anti-inflammatory Drugs (NSAID) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Non-steroidal Anti-inflammatory Drugs (NSAID) market is segmented into
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Segment by Application, the Non-steroidal Anti-inflammatory Drugs (NSAID) market is segmented into
Human
Animals
Others
Regional and Country-level Analysis
The Non-steroidal Anti-inflammatory Drugs (NSAID) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non-steroidal Anti-inflammatory Drugs (NSAID) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share Analysis
Non-steroidal Anti-inflammatory Drugs (NSAID) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-steroidal Anti-inflammatory Drugs (NSAID) business, the date to enter into the Non-steroidal Anti-inflammatory Drugs (NSAID) market, Non-steroidal Anti-inflammatory Drugs (NSAID) product introduction, recent developments, etc.
The major vendors covered:
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
1 Study Coverage
- 1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Introduction
- 1.2 Market Segments
- 1.3 Key Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Type
- 1.4.2 Salicylates
- 1.4.3 Propionic acid derivatives
- 1.4.4 Acetic acid derivatives
- 1.4.5 Enolic acid (Oxicam) derivatives
- 1.4.6 Anthranilic acid derivatives (Fenamates)
- 1.4.7 Selective COX-2 inhibitors (Coxibs)
- 1.4.8 Sulfonanilides
- 1.5 Market by Application
- 1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Growth Rate by Application
- 1.5.2 Human
- 1.5.3 Animals
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size, Estimates and Forecasts
- 2.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2015-2026
- 2.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2015-2026
- 2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID), Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Competitor Landscape by Players
- 3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers
- 3.1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Manufacturers (2015-2020)
- 3.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2015-2020)
- 3.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers
- 3.2.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2015-2020)
- 3.2.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2019
- 3.2.5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Manufacturers
- 3.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Base Distribution, Product Types
- 3.4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type
- 3.4.3 Date of International Manufacturers Enter into Non-steroidal Anti-inflammatory Drugs (NSAID) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type (2015-2020)
- 4.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Type (2015-2020)
- 4.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Type (2015-2020)
- 4.1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2021-2026)
- 4.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Type (2021-2026)
- 4.2.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Application (2015-2020)
- 5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Application (2015-2020)
- 5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Application (2015-2020)
- 5.1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2015-2020)
- 5.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2021-2026)
- 5.2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) by Country
- 6.1.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
- 6.1.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Type
- 6.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Application
7 Europe
- 7.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) by Country
- 7.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
- 7.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Type
- 7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) by Region
- 8.1.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region
- 8.1.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Type
- 8.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) by Country
- 9.1.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
- 9.1.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Type
- 9.3 Central & South America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) by Country
- 10.1.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country
- 10.1.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Type
- 10.3 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Description and Business Overview
- 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.1.5 Bayer Related Developments
- 11.2 Ecotrin
- 11.2.1 Ecotrin Corporation Information
- 11.2.2 Ecotrin Description and Business Overview
- 11.2.3 Ecotrin Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.2.5 Ecotrin Related Developments
- 11.3 Generic
- 11.3.1 Generic Corporation Information
- 11.3.2 Generic Description and Business Overview
- 11.3.3 Generic Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.3.5 Generic Related Developments
- 11.4 St. Joseph
- 11.4.1 St. Joseph Corporation Information
- 11.4.2 St. Joseph Description and Business Overview
- 11.4.3 St. Joseph Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.4.5 St. Joseph Related Developments
- 11.5 Elanco
- 11.5.1 Elanco Corporation Information
- 11.5.2 Elanco Description and Business Overview
- 11.5.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.5.5 Elanco Related Developments
- 11.6 Zoetis
- 11.6.1 Zoetis Corporation Information
- 11.6.2 Zoetis Description and Business Overview
- 11.6.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.6.5 Zoetis Related Developments
- 11.7 Boehringer Ingelheim
- 11.7.1 Boehringer Ingelheim Corporation Information
- 11.7.2 Boehringer Ingelheim Description and Business Overview
- 11.7.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.7.5 Boehringer Ingelheim Related Developments
- 11.8 Merial
- 11.8.1 Merial Corporation Information
- 11.8.2 Merial Description and Business Overview
- 11.8.3 Merial Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.8.5 Merial Related Developments
- 11.9 Merck Animal Health
- 11.9.1 Merck Animal Health Corporation Information
- 11.9.2 Merck Animal Health Description and Business Overview
- 11.9.3 Merck Animal Health Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.9.5 Merck Animal Health Related Developments
- 11.1 Bayer
- 11.1.1 Bayer Corporation Information
- 11.1.2 Bayer Description and Business Overview
- 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Products Offered
- 11.1.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Region
- 12.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions 2021-2026
- 12.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Regions 2021-2026
- 12.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast (2021-2026)
- 12.2.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast (2021-2026)
- 12.2.2 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast (2021-2026)
- 12.2.3 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2021-2026)
- 12.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast (2021-2026)
- 12.3.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast (2021-2026)
- 12.3.2 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast (2021-2026)
- 12.3.3 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast (2021-2026)
- 12.5.2 Latin America: Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs (NSAID) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Non-steroidal Anti-inflammatory Drugs (NSAID). Industry analysis & Market Report on Non-steroidal Anti-inflammatory Drugs (NSAID) is a syndicated market report, published as Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
